Qi Pei - Publications, H-index & Citations

Qi Pei

the third xiangya hospital of central south university

30H指数

190论文数

3.4K被引数

收录论文 60

发表时间

Yam-Derived Vesicles Alleviate Osteoarthritis via miRNA-Mediated Suppression of the TLR4–TRAF6 Signaling Axis 山药来源的囊泡通过miRNA介导的TLR4–TRAF6信号轴抑制缓解骨关节炎

Small

IF12.1

2026-09-22

PREAI

Junyan Liu; He Ke; Lingyu Su; Zhirou Lin; Chong Liu; Shilong Jiang; Hong Huang; Chengxian Guo; Qinghua Zhang; Huifang Tang; Zhaoqian Liu; Wenhu Zhou; Qi Pei; Qianfei Cui

Population pharmacokinetic/pharmacodynamic modeling of NH600001 reveals age-related differences in sedation response and supports individualized dosing in elderly patients NH600001的群体药代动力学/药效动力学模型揭示镇静反应的年龄相关性差异，并支持老年患者的个体化给药

Expert Opinion on Drug Metabolism & Toxicology

IF3.4

2026-09-17

PREAI

Ya-Jie Cao; Yun Kuang; Qi Gao; Kun-Hong Deng; Qi Pei; Ya-Xin Liu; Guo-Ping Yang

Using physiologically based pharmacokinetic modelling to optimize repaglinide and irbesartan dosing in Chinese population with SLCO1B1 polymorphism 利用生理药代动力学模型优化携带SLCO1B1多态性的中国人群瑞格列奈和厄贝沙坦的用药剂量

British Journal of Clinical Pharmacology

IF3

2026-09-15

PREAI

Yujie Wen; Zexu Sun; Hongyi Tan; Qin Ding; Shuqi Huang; Qinmin Deng; Xuanyi Li; Guoping Yang; Qi Pei

Machine Learning Enables Rapid Prediction of Acid-Reducing Agent Drug Interactions: A Streamlined Complement to PBPK Modeling 机器学习实现酸抑制剂药物相互作用的快速预测：PBPK建模的简化补充

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-15

OAAI

Yuanfang Qin; Lehua Yu; Tao Chen; Yonghui Zuo; Hongyun Wang; Guoping Yang; Qi Pei

Development of a Disease-Specific Virtual Malaria Population for Physiologically-Based Pharmacokinetic Modeling 开发用于生理药代动力学模型的疾病特异性虚拟疟疾人群

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-15

OAAI

Junjie Ding; Qi Pei; Richard M. Hoglund; Joel Tarning

Effect of adjunctive inhalation on the association between plasma AUC/MIC of polymyxin B and clinical efficacy in MDR gram-negative infections 联合吸入对多黏菌素B血浆AUC/MIC与MDR革兰阴性菌感染临床疗效关联的影响

Journal of Antimicrobial Chemotherapy

IF3.6

2026-07-14

PREAI

Shengnan Zhang; Yaqian Li; Hongyi Tan; Yejun Li; Yuanfang Qin; Tingting Wu; Jingjing Liu; Qi Pei

Polymyxin B Intravenous Administration Strategy Guided by Minimum Inhibitory Concentration in Critically Ill Patients With Pulmonary Infection: Insights From PBPK Modeling 基于最小抑菌浓度的多黏菌素B静脉给药策略在重症肺部感染患者中的应用：PBPK建模的启示

cpt: pharmacometrics & systems pharmacology

IF0

2026-06-19

OAAI

Shengnan Zhang; Nan Yang; Ruwei Yang; Yuanfang Qin; Tingting Wu; Cuifang Wu; Yueliang Xie; Jingjing Liu; Chun Liu; Qi Pei

In Vitro and In Silico Evaluation of Polymyxin B Aerosol Delivery in Adult Mechanical Ventilation 体外和计算机模拟评估多粘菌素B气溶胶在成人机械通气中的输送

Pharmaceutics

IF5.5

2026-03-04

OAAI

Shengnan Zhang; Guanlin Wang; Jingjing Liu; Xuejuan Zhang; Qi Pei

Synthesis of Odorless Sulfur-Based Polymers and Their High Load-Bearing Capacity as Extreme Pressure Lubricant Additives 无味硫基聚合物的合成及其作为极压润滑剂添加剂的高承载能力

Langmuir

IF3.9

2026-03-01

PREAI

Pei, Qi; Huang, Qing; Xu, Haozhe; Guo, Pingxia; He, Qun; Cai, Meirong; Zhou, Feng; Bu, Weifeng

Prediction of vancomycin exposure in patients with central nervous system infections using physiologically based pharmacokinetic modeling

Journal of Pharmaceutical Sciences

IF3.8

2026-02-05

PREAI

Ya-xin Liu; Yun Kuang; Jin-long Liu; Qi Pei; Li-ying Gong; Guo-ping Yang

Performance Evaluation of Nine Large Language Models in Anticoagulation Decision-Making for Non-Valvular Atrial Fibrillation 九种大语言模型在非瓣膜性心房颤动抗凝决策中的性能评价

Research and Practice in Thrombosis and Haemostasis

IF3.4

2026-01-14

OAAI

Yujie Wen; Zhenzhen Deng; Xiaoyan Wang; Liuping Deng; Guoping Yang; Tian Wu; Qi Pei

Quantification of Polymyxin E in Plasma and Epithelial Lining Fluid: Validation and Clinical Application 血浆和上皮衬液中的多黏菌素E定量：验证与临床应用

Journal of Pharmaceutical and Biomedical Analysis

IF3.1

2025-12-02

PREAI

Shengnan Zhang; Ruwei Yang; Hongyi Tan; Ruiying Xie; Yejun Li; Jingjing Liu; Chun Liu; Qi Pei

Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjects 纳库巴坦（OP0595）静脉输注后的药代动力学、安全性和耐受性：一项在健康中国男性受试者中进行的随机、双盲、安慰剂对照的I期临床试验

Clinical and Experimental Medicine

IF3.5

2025-12-02

OAAI

Hui Qiu; Tingting Wu; Lei Diao; Nianda Yu; Hong Chen; Xi Peng; Jie Huang; Jinlian Xie; Qian Wu; Shuang Yang; Xiaoyan Yang; Long Zeng; Qi Pei; Chengxian Guo; Guoping Yang

Development and Validation of a Chinese Obesity-Specific Physiological Database for PBPK Modeling 中国肥胖特异性生理数据库的开发与验证：用于PBPK建模

CLINICAL PHARMACOKINETICS

IF4

2025-12-01

PREAI

Yang, Ruwei; Wen, Yujie; Zhang, Shengnan; Yang, Guoping; Zhu, Liyong; Pei, Qi

Preparation and Properties of a Novel Tungsten Film 新型钨薄膜的制备与性能

JOM

IF2.3

2025-12-01

PREAI

Wang, Dong; Chen, Bao-yi; Wang, Yang; Wang, Shuai-nan; Pei, Qi; Guo, Rong-nan; Zhang, Bing-qian; Yuan, Zhi-hua